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Background: Epidemiological evidence indicates that diabetic patients have increased susceptibility to adverse
cardiovascular outcomes related to acute increases in exposures to particulate air pollution. However, mechanisms
underlying these effects remain unclear.
Methods: To evaluate the possible mechanisms underlying these actions, we assessed the systemic effects of diesel
exhaust particles (DEP) in control mice, and mice with streptozotocin–induced type 1 diabetes. Four weeks
following induction of diabetes, the animals were intratracheally instilled (i.t.) with DEP (0.4 mg/kg) or saline, and
several cardiovascular endpoints were measured 24 h thereafter.
Results: DEP caused leukocytosis and a significant increase in plasma C-reactive protein and 8-isoprostane
concentrations in diabetic mice compared to diabetic mice exposed to saline or non-diabetic mice exposed to DEP.
The arterial PO2 as well as the number of platelets and the thrombotic occlusion time in pial arterioles assessed in vivo
were significantly decreased following the i.t. instillation of DEP in diabetic mice compared to diabetic mice exposed to
saline or non-diabetic mice exposed to DEP. Both alanine aminotransferase and aspartate transaminase activities, as
well as the plasma concentrations of plasminogen activator inhibitor and von Willebrand factor were significantly
increased in DEP-exposed diabetic mice compared to diabetic mice exposed to saline or DEP-exposed non-diabetic
mice. The in vitro addition of DEP (0.25-1 μg/ml) to untreated mouse blood significantly and dose-dependently
induced in vitro platelet aggregation, and these effects were exacerbated in blood of diabetic mice.
Conclusion: This study has shown that systemic and coagulation events are aggravated by type 1 diabetes in mice,
acutely exposed to DEP and has described the possible mechanisms for these actions that may also be relevant to the
exacerbation of cardiovascular morbidity accompanying particulate air pollution in diabetic patients.
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Large body of epidemiological studies have suggested a
linkage between particulate air pollution and increased
cardiovascular morbidity and mortality [1,2]. Associations
between particulate matter with a diameter ≤ 2.5 μm (PM2.5)
and mortality exists even at low concentrations of air pollut-
ants [1,2]. These epidemiological observations have demon-
strated that particles not only exert respiratory effects, but
also increase cardiovascular morbidity and mortality [1,2].* Correspondence: anemmar@uaeu.ac.ae
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reproduction in any medium, provided the orAn important feature of the epidemiological associations
between air pollution and morbidity or mortality is that
the acute adverse effects of particulate air pollution appear
to be most marked in people with underlying cardiovascular
disease, or risk factors such as diabetes mellitus. Indeed,
several studies have reported that patients with diabetes
mellitus have increased susceptibility to adverse cardiovas-
cular outcomes related to acute increases in exposures to
air pollution [3-5].
The vast majority of cases of diabetes are categorized
into two broad groups. Type 1 diabetes (known as
insulin-dependent diabetes or juvenile-onset diabetes)
which is caused by a complete deficiency of insulinal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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destruction of the β cells of the pancreas. This form
represents about 10% of all forms of diagnosed dia-
betes. Type 2 diabetes which is much more prevalent
(90%) is caused by a combination of resistance to insulin
action and an inadequate compensatory insulin secretory
response [6,7]. It is well known that cardiovascular
complications including thrombosis constitute the major
cause of morbidity and mortality in both type 1 and
type 2 diabetes [7].
While several studies using type 2 animal model of
diabetes have been performed to verify whether or not, and
to what extent are the cardiovascular effects of exposure to
particulate air pollution exaggerated, experimental studies
investigating the effect of particles on animal model of type
1 diabetes are very limited. In relation to type 2 model of
diabetes, it has been demonstrated that chronic exposure
to PM2.5 in high-fat-fed nonatherosclerotic C57 mice
aggravates insulin resistance by enhancing inflammation in
adipose tissue [8]. More recently, it has been demonstrated
that long-term exposure to PM2.5 causes glucose intoler-
ance, insulin resistance and inflammation [9,10]. However,
using type 1 model of diabetes, as far as we are aware, only
one study has reported an aggravation in the increase of
8-Oxo-2′-deoxyguanosine (8-OHdG), a marker of oxidative
stress, and endothelin-1 in streptozotocin (STZ)-induced
type 1 diabetes in rats compared to non-diabetic ones
following the exposure to particulate air pollution [11].
There have been no previous experimental studies on the
acute effects of particulate air pollution on coagulation in
animal model of type 1 diabetes.
We have recently demonstrated that diesel exhaust
particle (DEP) equally increased airway resistance and
caused lung inflammation in both STZ-diabetic and
nondiabetic mice. However, the occurrence of pulmonary
oxidative stress and presence of apoptosis were only
seen in DEP-exposed diabetic mice, suggesting that
diabetes increased susceptibility to particulate air pollution
[12]. In the present study, we aimed at quantifying the
effects of pulmonary exposure to DEP in mice on cardio-
vascular parameters including pial arteriolar thrombosis
in vivo, platelet aggregation in vitro, some markers of
inflammation, oxidative stress and fibrinolysis in a mouse
model of type 1 diabetes.
Results
General characteristic of the diabetic-STZ and non-diabetic
mice
The mean body weight in diabetic mice (25.0 ± 1.8 g)
was significantly (P < 0.001) lower than that of non-
diabetic mice (31.6 ± 1.7 g). The mean blood glucose level
was significantly (P < 0.001) increased in diabetic mice
(557 ± 62.2 mg/dL) compared to that of non-diabetic mice
(130.0 ± 6.9 mg/dL).Effect of DEP on systemic inflammation and oxidative stress
Figure 1A shows that in diabetic mice, pulmonary exposure
to DEP causes leukocytosis. The leukocyte numbers
were increased in diabetic mice exposed to DEP com-
pared to diabetic mice exposed to saline or non-diabetic
mice exposed to DEP.
The plasma concentration of c-reactive protein (CRP)
was significantly increased following DEP exposure in
diabetic mice compared to diabetic mice exposed to saline
or non-diabetic mice exposed to DEP (Figure 1B).
The concentration of 8-isoprostane, a marker of oxidative
stress, was significantly increased after the pulmonary
exposure to DEP in diabetic mice versus diabetic mice
exposed to saline or non-diabetic mice exposed to DEP
(Figure 1C).
Effect of DEP on arterial PO2 and PCO2
In non-diabetic mice, i.t. instillation of DEP did not affect
the PaO2. The decrease in PaO2 was not statistically signifi-
cant between non-diabetic + saline versus diabetic + saline
mice. Interestingly, the PaO2 was significantly decreased
in diabetic mice exposed to DEP compared to diabetic
mice exposed to saline or non-diabetic mice exposed to
DEP (Figure 2A). No difference in the PaCO2 was found
between the 4 different groups (Figure 2B).
Effect of DEP on alanine aminotransferase (ALT) and
aspartate transaminase (AST) activities in plasma
In non-diabetic mice, DEP administration did not affect
the plasma activities of AST and ALT compared to saline-
exposed mice. No difference in the enzyme activities was
found between saline-treated diabetic and saline-treated
non-diabetic mice. However, the AST and ALT activities
were increased in DEP-exposed diabetic mice compared
to diabetic mice exposed to saline or DEP-exposed non-
diabetic mice (Figure 3).
Effect of DEP on circulating platelet numbers and
photochemically-induced thrombosis in pial arterioles
Figure 4A shows that in non-diabetic mice, DEP adminis-
tration did not affect the number of circulating platelets
compared to saline-exposed mice. No difference in platelet
numbers was found between saline-treated diabetic and
saline-treated non-diabetic mice. In diabetic mice exposed
to DEP, the number of platelets was significantly decreased
compared to saline-treated diabetic mice or DEP-treated
non-diabetic mice.
In non-diabetic mice treated with DEP, the thrombotic
occlusion time was significantly shortened compared
to saline-treated non-diabetic mice. Similarly, the throm-
botic occlusion time was significantly decreased in
DEP-treated diabetic mice versus saline-treated diabetic
mice. Interestingly, the degree of shortening in the oc-
clusion time was significantly greater in DEP-exposed
Figure 1 Effect of diesel exhaust particles (DEP) on leukocyte
numbers (A), C-reactive protein (CRP, B) and 8-isoprostane (C)
concentrations in plasma. The latter were measured 24 h
following intratracheal instillation of DEP (0.4 mg/kg) or saline in
non-diabetic and diabetic mice. Data are mean ± SEM (n = 8).
Nemmar et al. Particle and Fibre Toxicology 2013, 10:14 Page 3 of 10
http://www.particleandfibretoxicology.com/content/10/1/14diabetic mice compared to DEP-exposed non-diabetic
mice (Figure 4B).Effect of DEP on platelet aggregation in whole blood
in vitro
Figure 5 illustrates that low concentrations of DEP
(0.25–1 μg/ml blood) caused platelet aggregation in a
dose-dependent manner. In non-diabetic mouse blood,Figure 2 Effect of diesel exhaust particles (DEP) on arterial PO2
(A) and PCO2 (B). The latter were measured 24 h following
intratracheal instillation of DEP (0.4 mg/kg) or saline in non-diabetic
and diabetic mice. Data are mean ± SEM (n = 8).
Figure 3 Effect of diesel exhaust particles (DEP) on aspartate
transaminase (AST, A) and alanine aminotransferase (ALT, B)
activities in plasma. The latter were measured 24 h following
intratracheal instillation of DEP (0.4 mg/kg) or saline in non-diabetic
and diabetic mice. Data are mean ± SEM (n = 8).
Figure 4 Effect of diesel exhaust particles (DEP) on circulating
platelet numbers (A) and thrombotic occlusion time in pial
arterioles (B). The latter were measured 24 h following intratracheal
instillation of DEP (0.4 mg/kg) or saline in non-diabetic and diabetic
mice. Data are mean ± SEM (n = 8).
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(P < 0.005). In diabetic mouse blood, a clear dose-
dependent effect of DEP on platelet aggregation was ob-
served. The effect of DEP on platelet aggregation was
significant at 0.25 (P < 0.05), 0.5 (P < 0.0001) and 1
μg/ml (P < 0.0001). Moreover, in diabetic blood, the
effect observed at 1 μg/ml was statistically significant
(P < 0.0001) compared with the same dose in non-
diabetic mouse blood.Effect of DEP on plasma concentrations of von Willebrand
factor (vWF) and total plasminogen activator inhibitor-1
(PAI-1)
Figure 6A shows that DEP exposure in both diabetic
and non-diabetic mice causes a significant increase of
PAI-1 concentration compared to their respective con-
trols. PAI-1 was increased in a greater fashion in the
non-diabetic + saline group versus non-diabetic + DEP
group (+35%, P < 0.001) compared to diabetic + saline
versus diabetic + DEP (+21%, P < 0.01). The increase of
PAI-1 in diabetic mice exposed to DEP was significantly
higher compared to non-diabetic mice exposed to DEP
(+19%, P < 0.01).
The plasma concentration of vWF was not significantly
affected following DEP exposure in non-diabetic mice.
However, in diabetic mice exposed to DEP, vWF
Figure 5 Direct in vitro effect of diesel exhaust particles (DEP) on
platelet aggregation in whole blood of untreated non-diabetic
and diabetic mice. Platelet aggregation in untreated non-diabetic and
diabetic mouse whole blood 3 min after the addition of saline or DEP
(0.25-1 μg/ml) was assessed. The degree of platelet aggregation
following DEP exposure was expressed in percent of control
(saline-treated diabetic or non-diabetic blood). Data are mean ± SEM
(n = 3-5). *: P < 0.05 compared with saline-treated blood within the
same group. **: P < 0.005 compared with saline-treated blood within
the same group. ***: P < 0.0001 compared with saline-treated blood
within the same group. Δ: P < 0.0001 between diabetic and
non-diabetic groups for the same given DEP concentration.
Figure 6 Effect of diesel exhaust particles (DEP) on
plasminogen activator inhibitor 1 (PAI-1, A) and von Willebrand
factor (vWF, B) concentrations in plasma. The latter were measured
24 h following intratracheal instillation of DEP (0.4 mg/kg) or saline
in non-diabetic and diabetic mice. Data are mean ± SEM (n = 8).
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mice or DEP-exposed non-diabetic mice (Figure 6B).
Discussion
In the present study, we showed an increased cardiovascu-
lar vulnerability of diabetic mice to particulate air pollution.
We found an aggravation of the impact of acute exposure
to DEP in diabetic mice substantiated by increase of sys-
temic inflammation (leukocytosis and CRP), oxidative stress
(8-isoprostane), hypoxemia, hepatotoxicity and acceleration
of coagulation comprising thrombosis in vivo, platelet
aggregation in vitro, and the increase in plasma concentra-
tions of PAI-1 and vWF.
In the present study, we used a pertinent animal
model of type 1 diabetes, i.e. STZ-induced diabetes in
mice [11,13] and assessed the acute effects of a relevant
type of pollutant particles, namely DEP. The dose of
DEP used here 0.4 mg/kg (10 μg/mouse) is lower than
the dose previously tested, i.e. 0.5 mg/kg (15 μg/mouse)
or 1 mg/kg (30 μg/mouse) because we hypothesized that
the effects of DEP would be aggravated in STZ-induced
type 1 diabetes in mice. DEP was given to mice by i.t.
instillation because it provides more accurate dosing,
given that mice are nose breathers that filter most inhaled
particles [14]. In 2002, the United States Environmental
Protection Agency reported a range of maximal city PM10
concentrations between 26 and 534 μg/m3 [15]. Severallarge cities in the world have much higher levels of
PM10, with annual averages of 200 to 600 μg/m
3 and
peak concentrations frequently exceeding 1,000 μg/m3 [16].
Using the highest value in the United States and assuming
a minute ventilation of 6 l/min (~8.6 m3 over 24 hours) for
a healthy adult at rest, the total dose of PM inhaled over
24 hours would be 4,614 μg [17]. Exposure of a human to a
daily dose of 4,614 μg of PM would correspond to more
than 35 μg of PM exposure for a mouse (25 grams in size)
with minute ventilation of 35–50 ml/min [17]. The dose we
tested here (10 μg/mouse) is lower than the comparative
human dose of ± 35 μg/mouse reported by Mutlu et al. [17].
Nemmar et al. Particle and Fibre Toxicology 2013, 10:14 Page 6 of 10
http://www.particleandfibretoxicology.com/content/10/1/14Our data show that in non-diabetic mice, at the dose
and regimen studied, DEP did not affect the number of
leukocytes or the CRP concentration in plasma. Previously,
24 h post-exposure to higher doses of DEP, i.e. 15 μg/mouse
(0.5 mg/kg) or 30 μg/mouse (1 mg/kg), we found no
increase in the number of leukocytes [18,19]. No significant
differences were observed between control diabetic and
non-diabetic mice. Interestingly, DEP exposure induced a
leukocytosis and a significant increase of CRP, indicating
the occurrence of systemic inflammation. Our finding
corroborate epidemiological studies that have reported
positive associations between air pollution and indicators
of systemic inflammation such as leukocyte numbers,
interleukin 6 and CRP [3,20]. Remarkably, it has been
reported that these associations were stronger and most
consistent in individuals with diabetes [3]. We have recently
reported that repeated exposure to DEP causes an increase
in CRP concentration and that the pre-treatment with the
anti-inflammatory and antioxidant curcumin returned the
CRP concentrations to control levels [21].
We have recently demonstrated that 24 h following
their i.t. instillation, DEP (0.5 and 1 mg/kg) caused
pulmonary and systemic oxidative stress responsible for
systemic inflammation, and that the pretreatment with a
cysteine prodrug L-2-oxothiazolidine-4-carboxylic acid
abrogated these effects through its ability to balance
oxidant-antioxidant status [18]. In the present study, as a
marker for oxidative stress, we selected to measure the
plasma concentrations of 8-isoprostane. Isoprostanes are a
family of eicosanoids of nonenzymatic origin, produced by
the random oxidation of tissue phospholipids by oxygen
radicals. Elevated levels of isoprostanes have been found
in serum, plasma, and urine of heavy smokers [22] and
lung tissue of mice expose to carbon nanoparticles [23].
Here, we found that plasma 8-isoprostane concentrations
were significantly increased after the pulmonary exposure
to DEP in diabetic mice versus diabetic mice exposed
to saline or non-diabetic mice exposed to DEP. It is
well-established that oxidative stress plays a key role in
the pathogenesis of of diabetes mellitus [24]. Diabetic
patients usually have significantly elevated concentrations
of 8-OHdG in their serum and decreased levels of glutathi-
one [24]. Our data are in agreement with previous findings
which reported that PM2.5 exposure causes aggravation of
plasma oxidative stress in STZ-diabetic rats compared to
nondiabetic rats [11].
While PaCO2 was not affected by DEP in both dia-
betic and non-diabetic mice, the PaO2 was significantly
decreased in diabetic mice exposed to DEP compared
to diabetic mice exposed to saline or non-diabetic mice
exposed to DEP. We recently demonstrated that DEP
exposure in hypertensive mice significantly decreased
the PaO2 compared with DEP-treated normotensive
mice. Moreover, using a rat model of cisplatin-inducedacute renal failure, we have recently shown a decrease
in PaO2 following DEP exposure [25]. Our findings are
in agreement with epidemiological studies that sug-
gested that pollution may result in hypoxemia and that
these effects might be most relevant in older and sicker
individuals [26,27].
In non-diabetic mice, DEP administration did not
affect the plasma activities of AST and ALT compared
to saline-exposed mice. No difference in the enzyme
activities was found between saline-treated diabetic
and saline-treated non-diabetic mice. Remarkably, the
AST and ALT activities were increased in DEP-exposed
diabetic mice compared to diabetic mice exposed to saline
or DEP-exposed non-diabetic mice, indicating that DEP
causes tissue damage in diabetic mice. Exposure to PM2.5
in healthy mice did not affect AST and ALT activities [28].
However, it has been reported that pulmonary exposure of
obese diabetic mice to DEP causes an increase in the
activities of AST, ALT, the ratio of liver weight, and the
magnitude of fatty change of the liver in histology [29].
Epidemiological and clinical studies are needed to verify
the occurrence of liver injury following the exposure to
particulate air pollution in susceptible population.
A strong epidemiologic association has been observed
between increased levels of PM and hospitalizations for
heart disease among those who had diabetes compared
with those who did not [5]. The risk of coronary heart
disease, stroke, and peripheral arterial disease is increased
in persons with diabetes [30]. Several experimental
studies have reported that exposure to particles causes
prothrombotic effects in the ear vein of rats [31], femoral
vein and artery of hamsters [32-35] carotid artery of mice
[17] and pial venule or arterioles of mice [18,36]. Our data
confirms the occurrence of prothrombotic effects following
the exposure to DEP in non-diabetic mice compared to
saline-treated non-diabetic mice. Similarly, we found a
shortening in the thrombotic occlusion time in diabetic
mice exposed to DEP compared to those exposed to saline.
Interestingly, the degree of shortening in the thrombotic
occlusion time was significantly greater DEP-exposed
diabetic mice compared to DEP-exposed non-diabetic
mice. Recently, we reported an aggravation of thrombotic
events in hypertensive mice [19].
Along with the potentiation of prothrombotic effect in
diabetic mice exposed to DEP, we found a significant
decrease in platelet numbers in DEP-exposed diabetic
mice compared to DEP-exposed non-diabetic mice or
saline-exposed diabetic mice, this is indicative of platelet
activation in vivo. A decrease of platelet numbers following
exposure to particles has been reported from experimental
and clinical studies [18,37].
It has been suggested that inhaled particles may lead
to systemic inflammatory response through the release
of inflammatory mediators and oxidative stress within the
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showed that air pollution exposure is associated with rapid
changes in autonomic nervous system balance, favouring
sympathetic nervous system activation and parasympathetic
withdrawal [1,38]. Other lines of evidence also suggest that
nanoparticulate inhalation can rapidly translocate from
through the alveolar capillary barrier and directly affect the
cardiovascular system [1,38-40]. Because arteriolar throm-
bosis measured in vivo in our model depends mainly on
the intensity of the vascular lesion and subsequent platelet
recruitment and aggregation, we wanted to test the direct
effect of DEP on platelet aggregation in whole blood of
diabetic and non-diabetic mice in vitro. We, and others,
have previously reported that DEP cause platelet aggrega-
tion [36,41]. Our in vitro observations confirmed the occur-
rence of platelet aggregation following the addition of DEP.
Clearly, an aggravated effect was observed in diabetic
mouse blood with dose-dependent and significant graded
effects at 0.25, 0.5 and 1 μg/ml DEP. Interestingly, in dia-
betic blood, the effect observed at 1 μg/ml was statistically
significant compared with the same dose in non-diabetic
mouse blood. This in vitro finding corroborates our in vivo
observation. Such observation has, as far as we are aware,
never been reported before. Our data corroborate a recent
human study which reported that PM exposure was associ-
ated with a change in platelet function toward a greater
prothrombotic tendency in diabetic patients [42].
Exposure to DEP in both diabetic and non-diabetic
mice caused a significant increase of PAI-1 concentration
compared to their respective controls. However, PAI-1 was
increased in a greater fashion in the non-diabetic + saline
group versus non-diabetic +DEP (+35%) group compared
to diabetic + saline versus diabetic +DEP (+21%) mice. This
difference can be explained by the fact that the concentra-
tion of PAI-1 in diabetic + saline group was significantly
increased compared to non-diabetic + saline group. This
finding corroborates the study of Tagher et al. [43] who
found that PAI-1 concentration was significantly higher in
patient with type 1 diabetes compared to healthy controls.
We found a significant increase of circulating PAI-1 in
diabetic mice exposed to DEP compared to diabetic mice
exposed to saline or non-diabetic mice exposed to DEP.
Raised concentrations of circulating PAI-1 have been
acknowledged as an independent risk factor for the
development of ischemic cardiovascular events [44,45].
The concurrent increase of plasma PAI-1 and decrease
of PaO2 that we observed corroborate the finding of pinsky
et al. [46] who demonstrated that enhanced expression of
PAI-1 is an important mechanism suppressing fibrinolysis
under conditions of low oxygen tension. We recently
reported that repeated exposure to DEP in healthy mice
caused an increase of plasma PAI-1 concentration, and
another study showed an increase in PAI-1 mRNA and
protein concentrations in lung and adipose tissue of micetreated with PM [47]. Moreover, Erdely et al. [48] showed
that pulmonary exposure to carbon nanotube increased the
active form as well as total PAI-1 in the circulation. We also
found an increase of vWF in DEP-treated diabetic mice
compared to saline-treated diabetic mice or DEP-treated
non-diabetic mice. vWF reflects endothelial cell release and
probably vascular reactivity. Vascular reactivity could re-
sults from the oxidative stress or direct effects of DEP that
have presumably translocated into the systemic circulation.
Moreover, vWF can mediate platelet adhesion to damaged
endothelium, this could explain at least partly the observed
exaggerated prothrombotic effects of DEP in diabetic mice.
Elevated levels of vWF were observed in association with
increased concentrations of particulate matter in patients
with coronary heart disease [49]. In healthy mice, increased
vWF expression on hepatic endothelium was detected after
intraarterial administration of nanoparticles [50].
Collectively, our data show an aggravation of various
systemic and coagulation endpoints in vivo and in vitro
in diabetic mice acutely exposed to DEP compared to
non-diabetic mice exposed to DEP or diabetic mice
exposed to saline. These exacerbations could be ascribed
to the increase of systemic oxidative stress and inflamma-
tion observed particularly in diabetic mice exposed to DEP
(Figure 1). Indeed, both oxidative stress and inflammation
were reported to play a critical role in the cardiovascular
effects of particulate air pollution [1,18,36] and diabetes
[51]. Nevertheless, further studies are required clarify the
mechanisms underlying the effect of type 1 diabetes and
DEP on the cardiovascular system and whether the
observed effects are strain-dependent. A murine strain
differences in airway inflammation caused by DEP has
been previously reported [52].
We conclude that systemic and coagulation events are
aggravated in type 1 diabetic mice acutely exposed to DEP.
Our findings provide possible plausible explanation for the
exacerbation of cardiovascular morbidity accompanying
particulate air pollution in diabetic patients. Additional
experiments are needed to evaluate the chronic effect
of DEP on type 1 diabetes and determine whether the
observed effects are related to the DEP-associated
components or by particles themselves.
Material and methods
DEP
The DEP (SRM 2975) were obtained from the National
Institute of Standards and Technology (NIST, Gaithersburg,
MD, USA), and were suspended in sterile saline (NaCl 0.9%)
containing Tween 80 (0.01%). To minimize aggregation,
particle suspensions were always sonicated (Clifton
Ultrasonic Bath, Clifton, New Jersey, USA) for 15 min and
vortexed before their dilution and prior to intratracheal (i.t.)
administration. Control animals received saline containing
Tween 80 (0.01%).
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analyzed by transmission electron microscopy [53,54].
This has revealed the presence numerous small aggregates
of carbonaceous particles, and substantial amount of
ultrafine (nano)-sized particle (less than 100 nm) aggregates
were seen. Most of the observed aggregates were <1 μm in
the largest diameter [53,54].
The endotoxin concentration in the DEP solution
and saline used was quantified, as described by the
manufacturer, by chromogenic Limulus Amebocyte
Lysate (Pierce, Rockford, IL) test. The concentration
was lower than the detection limit (0.1 EU/ml) in the
saline and DEP solutions.Animals and treatments
This project was reviewed and approved by the Institutional
Review Board of the United Arab Emirates University,
College of Medicine and Health Sciences, and experiments
were performed in accordance with protocols approved
by the Institutional Animal Care and Research Advisory
Committee.
Male TO mice (HsdOla:TO, Harlan, UK) were housed
in light (12-h light:12-h dark cycle) and temperature-
controlled (22 ± 1°C) rooms. They had free access to
commercial laboratory chow and were provided tap
water ad libitum.
Type 1 diabetes mellitus was induced in male TO mice
(6 to 8 weeks old) by intraperitoneal (i.p.) injection of
200 mg/kg body weigh STZ (Sigma Chemical, St.
Louis, MO) [55,56]. Tail vein blood glucose samples
were measured before and during 4 weeks after injec-
tion to ensure induction of diabetes. The non-diabetic
(control) mice were injected i.p. with the vehicle
(0.1 mol/l citrate buffer, pH 4.5). Four-weeks post-STZ
injection, mice were anesthetized with sodium pento-
barbital (60 mg/kg, i.p.), placed supine with extended
neck on an angled board. A Becton Dickinson 24
Gauge cannula was inserted via the mouth into the tra-
chea. The DEP suspensions (0.4 mg/kg) or saline-only
were instilled intratrachealy (i.t.) (50 μl) via a sterile
syringe and followed by an air bolus of 50 μl to diabetic
or non-diabetic mice.Blood collection and analysis
24 h after the the i.t. administration of either saline or
DEP, the animals were anesthetized, as described above,
and blood was drawn from the inferior vena cava in EDTA
(4%). A sample was used for platelets and white blood cells
counting using an ABX VET ABC Hematology Analyzer
with a mouse card (ABX Diagnostics, Montpellier, France).
The remaining blood was centrifuged at 4°C for 15 min at
900 g and the plasma samples were stored at −80°C until
further analysis.Determination of CRP, 8-isoprostane, ALT, AST, vWF and
total PAI-1 levels in plasma
The concentrations of CRP (Uscn Life Science Inc,
Wuhan, China), 8-isoprostane (Cayman Chemicals,
Michigan, USA), PAI-1 (Molecular Innovation, Southfield,
MI, USA) and vWF (Uscn Life Science Inc, Wuhan, China)
were determined using ELISA Kits. The activities of
AST and ALT were measured using standard laboratory
methods with LX20 multiple automated analyser (Beckman
Coulter, CA, USA).
Arterial PO2 and PCO2 analysis
Arterial blood gases were measured in separate animals
following the protocol described above. Immediately after
the anesthesia, arterial blood was obtained via the
abdominal aorta with a heparinized 24-gauge needle.
Analysis was performed immediately after collection
with an OPTI CCA-TS blood gas analyzer (OPTI Medical,
Roswell, GA, USA).
Experimental pial cerebral arterioles thrombosis model
In a separate experiment, in vivo pial arteriolar
thrombogenesis was assessed 24 hours after the i.t.
instillation of either DEP or saline, according to a
previously described technique [18,36]. Briefly, the trachea
was intubated after induction of anesthesia with urethane
(1 mg/g body weight, i.p.), and a 2 F venous catheter
(Portex, Hythe, UK) was inserted in the right jugular vein
for the administration of fluorescein (Sigma, St. Louis,
MO, USA). After that, a craniotomy was first performed
on the left side, using a microdrill, and the dura was
stripped open. Only untraumatized preparations were
used, and those showing trauma to either microvessels or
underlying brain tissue were discarded. The animals were
then placed on the stage of a fluorescence microscope
(Olympus, Melville, NY, USA) attached to a camera and
DVD recorder. A heating mat was placed under the mice
and body temperature was raised to 37°C, as monitored by
a rectal thermoprobe connected to a temperature reader
(Physitemp Instruments, NJ, USA). The cranial preparation
was moistened continuously with artificial cerebrospinal
fluid of the following composition (mM): NaCl 124, KCl 5,
NaH2PO4 3, CaCl2 2.5, MgSO4.4, NaHCO3 23 and glucose
10, pH 7.3-7.4. A field containing arterioles 15–20 μm in
diameter was chosen. Such a field was taped prior to and
during the photochemical insult, which was carried out by
injecting fluorescein (0.1 ml/mouse of 5% solution) via the
jugular vein, which was allowed to circulate for 30–40 sec.
The cranial preparation was then exposed to stabilized
mercury light. The combination produces endothelium
injury of the arterioles. This, in turn, causes platelets
to adhere at the site of endothelial damage and then
aggregate. Platelet aggregates and thrombus formation
grow in size until complete vascular occlusion. The
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occlusion (time to flow stop) in arterioles were measured
in seconds. At the end of the experiments, the animals
were euthanized by an overdose of urethane.
Platelet aggregation in mouse whole blood
The platelet aggregation assay in whole blood was
performed, with slight modification, as described before
[57]. After anesthesia, blood from untreated diabetic
and non-diabetic mice was withdrawn from the inferior
vena cava and placed in citrate (3.2%), and 100-μl
aliquots were added to the well of a Merlin coagulometer
(MC 1 VET; Merlin, Lemgo, Germany). The blood samples
were incubated at 37.2°C with either saline (control) or
DEP (0.25-1 μg/ml) for 3 min, and then stirred for
another 3 min. At the end of this period, 25-μl sam-
ples were removed and fixed on ice in 225 ml cellFix
(Becton Dickinson). After fixation, single platelets were
counted in a VET ABX Micros with mouse card (ABX,
Montpellier, France). The degree of platelet aggregation
following DEP exposure was expressed as a ℅ of control
(saline-treated blood).
Statistics
Data were expressed as means ± SEM, and were analyzed
with GraphPad Prism Version 4.01 for Windows software
(Graphpad Software Inc., San Diego, USA). For the
in vivo results, comparisons between the four groups
were performed by analysis of variance ANOVA,
followed by Newman-Keuls multiple-range tests. For
the in vitro platelet aggregation data, comparison was
performed using unpaired student’s t-test. P values <0.05
are considered significant.
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